Advertisement
UK markets closed
  • NIKKEI 225

    39,341.54
    -325.53 (-0.82%)
     
  • HANG SENG

    17,716.47
    -373.46 (-2.06%)
     
  • CRUDE OIL

    81.86
    +0.96 (+1.19%)
     
  • GOLD FUTURES

    2,338.70
    +25.50 (+1.10%)
     
  • DOW

    39,164.06
    +36.26 (+0.09%)
     
  • Bitcoin GBP

    48,594.59
    +353.84 (+0.73%)
     
  • CMC Crypto 200

    1,281.85
    +15.70 (+1.24%)
     
  • NASDAQ Composite

    17,858.68
    +53.53 (+0.30%)
     
  • UK FTSE All Share

    4,460.27
    -20.39 (-0.46%)
     

Here's Why Icon PLC (ICLR) is a Strong Momentum Stock

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike.

Achieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that rates stocks based on popular investing methodologies, namely value, growth, and momentum. The Style Scores can help you narrow down which stocks are better for your portfolio and which ones can beat the market over the long-term.

Is This 1 Momentum Stock a Screaming Buy Right Now?

For momentum investors, upward or downward trends in a stock's price or earnings outlook take precedent, so they'll want to zero in on the Momentum Style Score. This Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings estimates.

ADVERTISEMENT

Icon PLC (ICLR)

Founded in Dublin, Ireland, in 1990, ICON Public Limited Company (“ICON plc”) is a clinical research organization (CRO). The company is a provider of outsourced development and services to pharmaceutical, biotechnology, medical device and government and public health organizations.

ICLR sits at a Zacks Rank #2 (Buy), holds a Momentum Style Score of B, and has a VGM Score of A. The stock is down 0.4% and up 0.5% over the past one-week and four-week period, respectively, and Icon PLC has gained 40.1% in the last one-year period as well. Additionally, an average of 486,114.81 shares were traded over the last 20 trading sessions.

A company's earnings performance is important for momentum investors as well. For fiscal 2024, seven analysts revised their earnings estimate higher in the last 60 days for ICLR, while the Zacks Consensus Estimate has increased $0.11 to $15.07 per share. ICLR also boasts an average earnings surprise of 0.8%.

Investors should take the time to consider ICLR for their portfolios due to its solid Zacks Ranks, notable earnings metrics, and impressive Momentum and VGM Style Scores.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

ICON PLC (ICLR) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research